Squarepoint
ATEX icon

Squarepoint’s Anterix ATEX Stock Holding History

Squarepoint’s Portfolio ATEX Stock Details ATEX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-12,500
Closed -$383K – 4553
2024
Q4 		$383K Buy
+12,500
New +$416K ﹤0.01% 3962

Other funds holding ATEX

OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
HCL
Heard Capital LLC Chicago, Illinois $1.93B AUM 21.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
PM
Plustick Management Charlottesville, Virginia $207M AUM 253.94% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Squarepoint's ATEX Position: Q1 2026 in Review

Squarepoint increased its Anterix (ATEX) stake by 12% in Q1 2026, buying an estimated $209K and bringing the position to 59,736 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #2085.

Squarepoint first reported a position in ATEX in Q1 2019 and has held it in 19 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Squarepoint held 59,736 shares of Anterix worth $2.28M as of Q1 2026.
  • Squarepoint bought 6,619 Anterix shares in Q1 2026, an estimated $209K.
  • Anterix made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2085 holding.
  • Squarepoint first reported a position in Anterix in Q1 2019 and has held it in 19 quarters since.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.